Home › Funds › Versant Venture Management, LLC › TPST
Versant Venture Management, LLC position in TPST
Tempest Therapeutics, Inc. · Health Care
Versant Venture Management, LLC reported holding 269,772 shares of TPST (Tempest Therapeutics, Inc.) in its Q3 2026 13F filing — a position valued at US$225K, representing 0.21% of its reported portfolio and ranking #8 among its reported holdings. Versant Venture Management, LLC has disclosed TPST holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Versant Venture Management, LLC's TPST position evolved
Versant Venture Management, LLC first disclosed a stake in TPST in Q4 2024 at 3,507,055 shares (US$2.9M). Across 8 filings, Versant Venture Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 269,772 shares valued at US$225K. Notable position changes include a 92% trim in Q2 2025 (shares rose 51% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 3.51M | $2.93M | New |
| Q1 2025 | 3.51M | $2.59M | Hold |
| Q2 2025 | 269.77K | $1.83M | Reduce |
| Q3 2025 | 269.77K | $2.77M | Hold |
| Q4 2025 | 269.77K | $774.25K | Hold |
| Q1 2026 | 269.77K | $442.43K | Hold |
| Q2 2026 | 269.77K | $299.45K | Hold |
| Q3 2026 | 269.77K | $225.07K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TPST and 13F data
TPST (Tempest Therapeutics, Inc.) is a Health Care company. 20 other funds we track also report a position in TPST. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Versant Venture Management, LLC
FAQ
How long has Versant Venture Management, LLC held TPST?
Versant Venture Management, LLC has disclosed TPST holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Versant Venture Management, LLC's current position in TPST?
As of Q3 2026, Versant Venture Management, LLC holds 269.77K shares of TPST (Tempest Therapeutics, Inc.), valued at $225.07K, representing 0.21% of its reported portfolio and ranking #8.
Has Versant Venture Management, LLC been buying or selling TPST?
In the latest 13F filing (Q3 2026), Versant Venture Management, LLC held unchanged its position in TPST.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.